YUSIMRY

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70114-220
  • Package NDC 70114-220-02
  • Application number BLA761216
  • SPL ID 92fff88b-7e54-47b3-92ed-e57bbb9b6a84
  • SPL set ID cd0e7af2-7704-49ce-bde9-f645294b6788
  • UNII FYS6T7F842
  • RxCUI 2640389
  • RxCUI 2640395
  • RxCUI 2640397
  • RxCUI 2640400

What the source publishes

Labeler
Coherus BioSciences Inc
Active ingredients
adalimumab-aqvh
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70114-220_92fff88b-7e54-47b3-92ed-e57bbb9b6a84
{
  "name": "YUSIMRY",
  "splId": "92fff88b-7e54-47b3-92ed-e57bbb9b6a84",
  "labels": [
    {
      "setId": "cd0e7af2-7704-49ce-bde9-f645294b6788",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd0e7af2-7704-49ce-bde9-f645294b6788",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd0e7af2-7704-49ce-bde9-f645294b6788"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Coherus BioSciences Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 SYRINGE, GLASS in 1 CARTON (70114-220-02)  / .8 mL in 1 SYRINGE, GLASS",
      "package_ndc": "70114-220-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230701"
    }
  ],
  "productId": "70114-220_92fff88b-7e54-47b3-92ed-e57bbb9b6a84",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "70114-220",
  "deaSchedule": null,
  "genericName": "adalimumab-aqvh",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ADALIMUMAB",
      "strength": "40 mg/.8mL"
    }
  ],
  "applicationNumber": "BLA761216",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230701",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175610",
      "N0000175451",
      "M0001357"
    ],
    "unii": [
      "FYS6T7F842"
    ],
    "rxcui": [
      "2640389",
      "2640395",
      "2640397",
      "2640400"
    ],
    "spl_set_id": [
      "cd0e7af2-7704-49ce-bde9-f645294b6788"
    ],
    "pharm_class_cs": [
      "Antibodies, Monoclonal [CS]"
    ],
    "pharm_class_epc": [
      "Tumor Necrosis Factor Blocker [EPC]"
    ],
    "pharm_class_moa": [
      "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
    ],
    "manufacturer_name": [
      "Coherus BioSciences Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70114-220_92fff88b-7e54-47b3-92ed-e57bbb9b6a84"